Skip to Content

Nystatin Oral Suspension

Last Updated: July 18, 2012
Status: Resolved

Products Affected - Description

Nystatin Oral Suspension, 100,000 units/mL

Reason for the Shortage

  • Fougera and Actavis have discontinued nystatin oral suspension.
  • Qualitest states the reason for the shortage was a raw materials shortage.
  • Taro and PAI could not provide a reason for the shortage.

Available Products

Nystatin Oral Suspension, 100,000 units/mL, Morton Grove
60 mL (NDC 60432-0537-60)
473 mL (NDC 60432-0537-16)

 
Nystatin Oral Suspension, 100,000 units/mL, Pharmaceutical Associates, Inc (PAI)
5 mL unit-dose (NDC 00121-4785-05)

Nystatin Oral Suspension, 100,000 units/mL, Precision Dose
5 mL unit-dose, package of 100 (NDC 68094-0599-61)
5 mL oral syringes, package of 50 (NDC 68094-0599-58)
5 mL unit-dose, package of 30 (NDC 68094-0599-62)
 
Nystatin Oral Suspension, 100,000 units/mL, Qualitest
60 mL (NDC 00603-1481-49)
473 mL (NDC 00603-1481-58)
 
Nystatin Oral Suspension, 100,000 units/mL, Taro
60 mL (NDC 51672-4117-04)
473 mL (NDC 51672-4117-09)
 
Nystatin Oral Suspension, 100,000 units/mL, Vista Pharm
5 mL unit-dose, packages of 50 (NDC 66689-0037-50)

Estimated Resupply Dates

All presentations are available.

Related Shortages

Updated

July 18, 2012; May 22, 2012; May 17, 2012; April 18, 2012; March 7, 2012; February 8, 2012; January 25, 2012; January 4, 2012; November 8, 2011; October 18, 2011; October 4, 2011, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide